15.06.2026
Keltie has achieved its strongest-ever result in the Financial Times Europe’s Leading Patent Law Firms 2026 report, receiving Gold rankings across all six areas of expertise.
Thank you
The result places Keltie among only 8 European patent law firms to receive the highest ranking across every assessed area. It also marks the eighth consecutive year Keltie has been recognised by the Financial Times, having featured every year since the ranking began.
Published annually by the Financial Times in partnership with Statista, Europe’s Leading Patent Law Firms identifies highly recommended patent law firms across Europe for patent prosecution and patent strategy consultation. The rankings are based on recommendations from clients and peers, with Gold awarded to firms that are very frequently recommended.
This year’s result represents a further step forward for Keltie, with the Chemistry and Pharmacy category moving from a silver to gold ranking, completing a clean sweep across all six areas of expertise:
Devanand Crease, Head of Chemistry and Life Sciences, commented:
“I’m delighted that our Chemistry and Pharmacy ranking has moved from silver to gold this year. It means a great deal to all of us in the team. These rankings are built entirely on what clients and peers say about us, so this reflects the depth of expertise across the team and the trust our clients place in us every day. I’m proud of the work, and of the people behind it.”
The result reflects the breadth of Keltie’s patent expertise across technologies and sectors, as well as the strength of the firm’s relationships with clients and peers across Europe.
View the full Financial Times ranking here.
Thank you
